– October 1, 2013
October 1, 2013
View Archives Issues
-
Aromatase Inhibitor-induced Arthralgia
Aromatase inhibitor-induced arthralgia develops by week 6 of initiating aromatase inhibitor (AI) therapy, and does not appear to resolve. -
Modern Radiation Therapy and ADT for High-risk Prostate Cancer Result in Improved Survival
Historically, men with high risk prostate cancer were believed to have low survival rates after definitive treatment with either surgery or radiation. -
Sorafenib + TACE for Advanced HCC
In an observational cohort of 222 hepatocellular cancer patients treated in China, transarterial chemoembolization (TACE) combined with sorafenib resulted in outcomes in terms of response rates and survival that compare favorably with prior series of sorafenib used alone. -
Two-step Ovarian Cancer Screening: A ‘Scissor-step’ Forward?
An 11-year prospective screening trial in 4051 menopausal women (age 50-74) demonstrates that the risk of ovarian cancer algorithm probability index. -
Physician Communication and Prostate Cancer Screening
A brief web intervention improved shared decision making regarding prostate cancer screening. -
Clinical Briefs in Primary Care
Evidence-based updates in primary care medicine By Louis Kuritzky, MD Supplement to Clinical Cardiology Alert, Clinical Oncology Alert, Critical Care Alert, Hospital Medicine Alert, Infectious Disease Alert, Neurology Alert, OB/GYN Clinical Alert, Primary Care Reports. -
Pharmacology Watch: More Side Effects of Fluoroquinolones Coming to Light